Literature DB >> 25359286

Association of polymorphisms of angiotensin I converting enzyme 2 with retinopathy in type 2 diabetes mellitus among Chinese individuals.

N Meng1, Y Zhang1, J Ma1, H Li1, F Zhou1, Y Qu1.   

Abstract

AIMS: To examine the association of Angiotensin I converting enzyme 2 (ACE2) gene polymorphisms and retinopathy in a Chinese type 2 diabetes mellitus (T2DM) cohort.
METHODS: A total of 743 T2DM participants were involved in this study including 408 female and 335 male cases. Female cases were divided into two groups: diabetes without retinopathy (DNR group, n=171) and with retinopathy (DR group, n=237), the latter was further subclassified into nonproliferative DR (NPDR group, n=121) and proliferative DR (PDR group, n=116). Male cases were assigned to DNR group (n=153) and DR group (n=182) which was further grouped into NPDR group (n=86) and PDR group (n=96). Two single nucleotide polymorphisms (SNPs; rs2074192 and rs714205) in ACE2 gene were genotyped.
RESULTS: In female cases, the frequency of genotypes TT in rs2074192 and CC in rs714205 were higher in DR and PDR group than in DNR group (P<0.05). The frequency of alleles T in SNP rs2074192 and C in SNP rs714205 was higher in DR group (P<0.05) and PDR group (P<0.05) than in DNR group. The frequency of allele T in SNP rs2074192 was higher in PDR group (P=0.04) than in NPDR group. The frequency of haplotype TC and CG was higher in DR and PDR groups, respectively (P<0.05). No positive results were found in male cases.
CONCLUSIONS: Our results revealed that SNPs rs2074192 and rs714205 in ACE2 gene were associated with the susceptibility of DR and PDR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25359286      PMCID: PMC4330274          DOI: 10.1038/eye.2014.254

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  26 in total

1.  Biochemistry and molecular cell biology of diabetic complications.

Authors:  M Brownlee
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

2.  Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling.

Authors:  Takehide Ogihara; Tomoichiro Asano; Katsuyuki Ando; Yuko Chiba; Hideyuki Sakoda; Motonobu Anai; Nobuhiro Shojima; Hiraku Ono; Yukiko Onishi; Midori Fujishiro; Hideki Katagiri; Yasushi Fukushima; Masatoshi Kikuchi; Noriko Noguchi; Hiroyuki Aburatani; Issei Komuro; Toshiro Fujita
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

3.  Report of the expert committee on the diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

4.  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

5.  Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats.

Authors:  P O Carlsson; C Berne; L Jansson
Journal:  Diabetologia       Date:  1998-02       Impact factor: 10.122

6.  Elevated serum levels of angiotensin-converting enzyme in patients with diabetic retinopathy.

Authors:  I N Migdalis; V Iliopoulou; K Kalogeropoulou; K Koutoulidis; M Samartzis
Journal:  South Med J       Date:  1990-04       Impact factor: 0.954

Review 7.  Renin angiotensin system and gender differences in the cardiovascular system.

Authors:  Marcus Fischer; Andrea Baessler; Heribert Schunkert
Journal:  Cardiovasc Res       Date:  2002-02-15       Impact factor: 10.787

8.  A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.

Authors:  M Donoghue; F Hsieh; E Baronas; K Godbout; M Gosselin; N Stagliano; M Donovan; B Woolf; K Robison; R Jeyaseelan; R E Breitbart; S Acton
Journal:  Circ Res       Date:  2000-09-01       Impact factor: 17.367

Review 9.  Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups.

Authors:  B I Hudson; M H Stickland; P J Grant
Journal:  Diabetes       Date:  1998-07       Impact factor: 9.461

Review 10.  ACE2, a new regulator of the renin-angiotensin system.

Authors:  Louise M Burrell; Colin I Johnston; Christos Tikellis; Mark E Cooper
Journal:  Trends Endocrinol Metab       Date:  2004 May-Jun       Impact factor: 12.015

View more
  9 in total

1.  ACE2 as Drug Target of COVID-19 Virus Treatment, Simplified Updated Review.

Authors:  Gomaa Mostafa-Hedeab
Journal:  Rep Biochem Mol Biol       Date:  2020-04

Review 2.  Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection.

Authors:  Soudeh Ghafouri-Fard; Rezvan Noroozi; Mir Davood Omrani; Wojciech Branicki; Ewelina Pośpiech; Arezou Sayad; Krzysztof Pyrc; Paweł P Łabaj; Reza Vafaee; Mohammad Taheri; Marek Sanak
Journal:  Vascul Pharmacol       Date:  2020-05-11       Impact factor: 5.773

Review 3.  Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification.

Authors:  Vince Kornél Grolmusz; Anikó Bozsik; János Papp; Attila Patócs
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

Review 4.  ACE2: the molecular doorway to SARS-CoV-2.

Authors:  Miriam Marlene Medina-Enríquez; Sandra Lopez-León; José Alberto Carlos-Escalante; Zuleika Aponte-Torres; Angelica Cuapio; Talia Wegman-Ostrosky
Journal:  Cell Biosci       Date:  2020-12-30       Impact factor: 7.133

5.  Analysis of the SARS-CoV-2-host protein interaction network reveals new biology and drug candidates: focus on the spike surface glycoprotein and RNA polymerase.

Authors:  Esen Sokullu; Maxime Pinard; Marie-Soleil Gauthier; Benoit Coulombe
Journal:  Expert Opin Drug Discov       Date:  2021-04-06       Impact factor: 6.098

Review 6.  COVID-19-A Theory of Autoimmunity Against ACE-2 Explained.

Authors:  Philip McMillan; Thomas Dexhiemer; Richard R Neubig; Bruce D Uhal
Journal:  Front Immunol       Date:  2021-03-23       Impact factor: 7.561

Review 7.  The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy.

Authors:  Fei Chen; Yankun Zhang; Xiaoyun Li; Wen Li; Xuan Liu; Xinyu Xue
Journal:  Front Cell Infect Microbiol       Date:  2021-10-22       Impact factor: 5.293

8.  ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus.

Authors:  Cheng Liu; Yanfang Li; Tianwang Guan; Yanxian Lai; Yan Shen; Abudurexiti Zeyaweiding; Haiyan Zhao; Fang Li; Tutiguli Maimaiti
Journal:  Cardiovasc Diabetol       Date:  2018-09-18       Impact factor: 9.951

9.  Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein.

Authors:  Mushtaq Hussain; Nusrat Jabeen; Fozia Raza; Sanya Shabbir; Ayesha A Baig; Anusha Amanullah; Basma Aziz
Journal:  J Med Virol       Date:  2020-04-15       Impact factor: 20.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.